chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A few days after the second dose, I started experiencing heart palpitations - racing heart, extremely high heart rate sometimes in the middle of sleep for no reason. Extremely high, frightening levels every other day or so when just sitting, but constantly beating faster than normal all hours of the day. This made exercise at high intensity very difficult, and blood pressure was also elevated. Uncomfortability, almost pressure-like sensations felt in the area of the chest. I spoke to my regular Doctor and he referred me to a heart specialist where a 2-week heart monitor was prescribed.  I only suspect that the vaccine has something to do with the condition - I am very fit, I exercise and take good care of my body and have never experienced any issues with my heart whatsoever (including blood pressure) until after the second dose of the vaccine. I felt it is important to report this.   After a couple of weeks of experiencing the worst of it, it has started to subside but my heart has yet to return to the normal levels prior to the second dose. I still feel it beats at a higher-than-normal rate during exercise.
Dizzy 10:14          HR =82     SPO2=98%               BP=129/89 10:25           HR= 70     SPO2=99%               BP=128/86 Recorded by RN
approx 22 days p/vax pt devel rash on pt extremities; dx by medical center w/vax react; dx: contact dermatitis
This case was reported by a physician and described the occurrence of swelling injection site in a 51 year old female subject who was vaccinated with Twinrix for prophylaxis.  Medical history included non-smoker and gastro-esophageal reflux disease. Concurrent medication included Nexium. On 22 September 2005 the subject received 1st dose of Twinrix. On 23 September 2005, 1 day after vaccination with Twinrix, the subject experienced swelling injection site, injection site redness and heat at injection site. The subject was treated with Benadryl. The events resolved on 24 September 2006. The physician considered the events to be related to vaccination with Twinrix.
Information regarding Flumist (2003-2004 Formula)(influenza virus vaccine, live intranasal (2003-2004 formula) nasal solution (frozen)) was received from a mother regarding her 6 year old daughter who experienced a runny nose and rash on her back.  At 6 years of age, the pt received a dose on 12/12/03. The pt had no relevant medical history. Indication for Flumist (2003-2004 Formula) was immunization.  Product was administered on 12/12/03.  Dose regimen was 0.5mL (IN). Pt was not taking concomitant therapy.  On 12/13/03, 1 day post-immunization, the child experienced a runny nose which lasted for 2 days.  On 12/17/03, she developed a rash on her back. The rash persisted as of 12/19/03.  No additional information was available at the time of this report.
After my vaccination and  leaving Pharmacy, I was experiencing pain in my left arm . I assumed it was from the injection, and that the pain would go away. I noticed the pain wasn't going away and that it was hard to raise my left arm. I'm experiencing dull pain, weakness in my arm, and a reduced range of motion. I have not contacted a health care provider because I keep thinking it's going to get better, but I realize it's still the same.
p/vax pt arm began to feel achy, by evening arm began to be swollen & red;next day fever started that lasted 5 days;rt arm red & swollen & white wide ban ran down to elbow;saw MD given cortisone & told it was allerg rxn;no more td;
15 minutes, post vax, the client's right palm became numb. It is still numb at 11:00. The vaccination was done off site. At 16:50, call to client and states the feeling has returned.
Marked swelling, erythema, tenderness and moderate induration appearing after administration. Symptoms resolved within 72 of onset.
Pt vaccinated with Meruvax II developed fever. MD felt fever was related to an URI that the pt caught from a sibling.
Patient is a 18 y.o. male who witnessed syncopal episode at 1605 yesterday s/p COVID vaccine. Patient says that he received a COVID vaccination yesterday at 1601. Per mother, the patient had a syncopal episode at 1605, he was sitting down and slid out of his chair with full extension of bilateral arms and legs, lasting about 30 seconds. Witnesses deny headstrike or shaking during syncopal episode. The patient denies pain. He states that he only ate cereal yesterday morning and has experienced similar symptoms in the past while receiving other shots. Patient denies recent trauma or fall. HA, confusion, changes in vision/speech, changes in gait, fever, chills, n/v, abdominal pain, chest pain, SOB, palpitations, cough, hemoptysis, back pain, neck pain, dysuria, hematuria, recent sick contact or travel. Otherwise has no complaints at this time.    Patient was discharged at 16:54 and given educational materials on understanding vasovagal syncope
Around 9 to 10 pm, sore arm developed. Over an hour or so the pain spread to the other arm and then throughout the whole body.  Fever and chills also developed. Pain described as debilitating. Vomiting started around 2 am. Vomiting several times over the course of 3 hours. Pt unsure if she ate something bad or not. No problems with breathing. No allergic reaction like symptoms, but patient takes benadryl OTC. Pt unable to leave bed until 3pm. Still currently feeling sore throughout body. Pt's last migraine 2 weeks ago, lasted about an hour.
Vomiting 5 minutes after Tdap administration. Vomiting continued for 5 days. Malaise, decreased appetite, headache, and vomiting. Prior vaccines given elsewhere.
Having issues with left arm. Now unable to lift arm above head. Having numbness from shoulder to fingers and fingers swelling.
scattered vesicular & scabbed lesions on torso scalp & extremities;none on oral mucosa;80 lesions assoc low grade fever (100.4 in the office);gen atopic maculopapular lesions;med prescribed;lesions scabbed
9 days after flu vaccine, developed numbness of (L) arm, worse as day progresses.
Systemic: Fainting / Unresponsive-Medium, Systemic: Weakness-Medium
Information has been received from a health professional concerning two female patients who were vaccinated intramuscularly with their third dose of Gardasil.  Within about two weeks, the patients experienced genital warts.  Both patients said they were not sexually active for about 5 months.  Additional information has been requested.
Complete hearing loss in right ear. Has improved slightly. Being treated w/DEBROX and prednisone.
Temp 101.2, vomitings, difficulty breathings, lung congestion, cough, sore throat. Thur - flu shot. Fri - pneumonia vac - Sat temp 101.2.
As per mother daughter with history of fainting at Dr. offices and dentist. Pt. nervous. Pt fainted and I and mother broke fall. Pt fainted less than a minute. As per pt ok and felt fine. Did not have breakfast.
Migraine; Terrible metallic taste; Didn't feel good; Low titers; High temperature; Felt lousy; This case was reported by a nurse via call center representative and described the occurrence of migraine in a female patient who received Hepatitis B vaccine for prophylaxis.   Co-suspect products included Hepatitis B vaccine for prophylaxis and Hepatitis B vaccine for prophylaxis.   On an unknown date, the patient received the 3rd dose of Hepatitis B vaccine, the 1st dose of Hepatitis B vaccine and the 2nd dose of Hepatitis B vaccine. On an unknown date, unknown after receiving Hepatitis B vaccine and not applicable after receiving Hepatitis B vaccine and Hepatitis B vaccine, the patient experienced migraine, taste metallic, feeling unwell, therapeutic response decreased, high temperature and feeling bad. On an unknown date, the outcome of the migraine, taste metallic, feeling unwell, therapeutic response decreased, high temperature and feeling bad were unknown.   It was unknown if the reporter considered the migraine, taste metallic, feeling unwell, therapeutic response decreased, high temperature and feeling bad to be related to Hepatitis B vaccine. It was unknown if the reporter considered the therapeutic response decreased to be related to Hepatitis B vaccine and Hepatitis B vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The patient experienced a temperature and felt lousy after receiving her third dose. The patient had to have titers drawn, and after 3-4 years following series completion, titers were low. The patient only received only 0.05ml of Hepatitis B vaccine and experienced a migraine, terrible metallic taste and did not feel good at all. The patient consented to follow up.      Lab Comments: On an unknown date lab test was performed
Pale, lightheaded after vaccine administration BP 92/64; P=78; had not eaten in several hours.
Patient was in observation, second floor after receiving second dose of Pfizer vaccination. Patient reported feeling nausea and had an itchy throat. Patient fainted from standing position to floor. patient placed in side-lying position and began seizure-like activity for one minute. 10:47 AM vitals- BP 126/67, HR 91, 100% 02 sat RA. Patient became responsive, sat up then proceeded with seizure-like activity for second time less than one minute. 10:50 AM Vitals- BP 113/38, HR 60, 100% 02 sat RA. Patient remained in side-lying position, head protected and EMS in route. 10:55 AM -patient responsive and mother present when transported by EMS to ED. 1100- patient left observation room alert and oriented.
Emesis began 72 hours after Rotateq, Pediarix, Prevnar and Pedvax.  Non bloddy, nonbilious emesis continued until 11/5 when ED visit and admission in early AM 11/6 took place. Also low grade fever transient and a few loose but not watery green stools.  Soy formula fed throughout.
62 days since she had the first dose; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (62 days since she had the first dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (62 days since she had the first dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (62 days since she had the first dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was provided. No concomitant medication were reported.  The patient would be 62 days since had the first dose. Pharmacist did not had any more information about the patient because the patient got the first dose from another location.   Reporter did not allow further contact
Friday mid morning temp of 100/low grade fever for 5 days; did not feel well over all; No appetite for 3 days; Stomach ache; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP). The reporter is the patient.  A 58 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 14Oct2021 (Lot number: ew0172) at the age of 58 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "High blood pressure" (unspecified if ongoing); "known allergies: penicillin" (unspecified if ongoing); "known allergies: sulfa" (unspecified if ongoing); "known allergies: bee stings" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: ej1685), administration date: 22Dec2020, when the patient was 57 years old, for Covid-19 immunization; Bnt162b2 (Dose Number: 2, Batch/Lot No: el3248), administration date: 12Jan2021, when the patient was 57 years old, for Covid-19 immunization. The following information was reported: PYREXIA (non-serious) with onset 15Oct2021, outcome "unknown", described as "Friday mid morning temp of 100/low grade fever for 5 days"; MALAISE (non-serious) with onset 15Oct2021, outcome "unknown", described as "did not feel well over all"; DECREASED APPETITE (non-serious) with onset 15Oct2021, outcome "unknown", described as "No appetite for 3 days"; ABDOMINAL PAIN UPPER (non-serious) with onset 15Oct2021, outcome "unknown", described as "Stomach ache". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pyrexia, malaise, decreased appetite, abdominal pain upper.  Additional information: No other vaccine received in four weeks. The patient only had issues with the 3rd dose the booster. Received shot on a Thursday afternoon. Friday mid morning temp of 100 did not feel well over all, Temp continued to go up. No appetite for 3 days. Stomach ache and low grade fever for 5 days . No covid prior vaccination. Not tested for covid post vaccination. No follow-up attempts are possible. No further information is expected.
after the first vaccine he had chills and fatigue with the first shot; after the first vaccine he had chills and fatigue with the first shot; This is a spontaneous report received from contactable reporter(s) (Other HCP and Consumer or other non HCP). The reporter is the patient.  A 40 year-old male patient received bnt162b2 (BNT162B2), administration date 18Mar2021 (Lot number: ER8727) at the age of 39 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CHILLS (non-serious), FATIGUE (non-serious) all with onset 2021, outcome "unknown" and all described as "after the first vaccine he had chills and fatigue with the first shot".  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202101761121 same patient, different vaccine dose/AE.
Volume/Intensity of Migraines spiked after the 2nd vaccination shot.  Normally, the Emgality lowers my severe migraine volume from daily to 1-2 times/month.  The shot was received 20 days into the 28 day cycle.  I was having to take the rizatriptan daily to attempt to mitigate.  Volume/Intensity returned to normal Emgality levels after the next injection, taken on 28 February.
This spontaneous report as received from a nurse refers to an 11 years old patient (unknown gender). No concurrent condition, medical history or allergy/drug reactions were reported. On 21-APR-2015, the patient was vaccinated with improperly stored (exposed to 52.8 Fahrenheit for a total of 105 hours) GARDASIL injection, dose number 1, lot # K006960, exp. date: 19-FEB-2017 (dose, strength and route unspecified). No concomitant medications were reported. No adverse experiences have been reported so far. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information is not expected, no contact details were provided.
This spontaneous report as received on 28-OCT-2015 from a registered nurse. On an unknown date, an unspecified patient experienced pain at the injection site from administration of GARDASIL 9. The nurse believed the patient was sent to physical therapy because of the reaction. No further information was provided. The outcome of pain at the injection site was not provided. This is one of several reports received from the same reporter. Additional information has been requested.
pt recvd Engerix-B & 5 days later had herpes zoster; seen by MD recvd med;
R arm (injection site) with golf ball-sized red, warm, hardened area, no opening in skin, no vesicles, painful and intermittent itching. Noticed pain & swelling 3/17/10 (injection 3/16/10). Hydrocortisone cream applied, pt. going home after P.M. shift now, will take ADVIL, BENADRYL, and apply ice packs.
CHEST COUGH; UPSET STOMACH; CHILLS; HEADACHE; FEVER; DIZZINESS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 31-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On APR-2021, treatment medications included: paracetamol. On 01-APR-2021, the subject experienced dizziness. On 01-APR-2021, the subject experienced chills. On 01-APR-2021, the subject experienced headache. On 01-APR-2021, the subject experienced fever. On an unspecified date, the subject experienced chest cough, and upset stomach. Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 101.5 F, 97.4 F, and Lung function tests (NR: not provided) Clear. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from dizziness, chills, headache, fever, chest cough, and upset stomach. This report was non-serious.
red, swollen, hot, tender area of rt deltoid; scattered petechiae around the area general malaise since onset; loss of 42 lbs body weight; debility, not able to work; poss local rxn from tetanus; poss allergic rxn; infected
I had my vaccination on 10/24/2021. On 11/23/2021 I had had the headache and drooping of the left side. I was diagnosed again with Bells Palsy. It lasted for a couple of days.
Vial stored at room temperature on counter under a cup and away from light after post puncture for 21 hrs; No adverse event; Moderna vaccine administered over 12 hours post puncture; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine administered over 12 hours post puncture), PRODUCT STORAGE ERROR (Vial stored at room temperature on counter under a cup and away from light after post puncture for 21 hrs) and NO ADVERSE EVENT (No adverse event) in a 79-year-old male patient who received mRNA-1273 (Spikevax) (batch nos. 006M21A and 052B22A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Aug-2022, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) .5 milliliter. On 09-Sep-2022 at 9:30 AM, received second dose of mRNA-1273 (Spikevax) (Intramuscular) dosage was changed to .5 milliliter. On 09-Sep-2022 at 9:30 AM,  after starting mRNA-1273 (Spikevax), the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine administered over 12 hours post puncture). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial stored at room temperature on counter under a cup and away from light after post puncture for 21 hrs) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine administered over 12 hours post puncture), PRODUCT STORAGE ERROR (Vial stored at room temperature on counter under a cup and away from light after post puncture for 21 hrs) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine administered over 12 hours post puncture) and PRODUCT STORAGE ERROR (Vial stored at room temperature on counter under a cup and away from light after post puncture for 21 hrs).    No concomitant medications were reported. It was stated that Moderna vaccine was removed from fridge on 08-Sep-2022, at 12:03 PM, was not discarded at midnight, morning on 09-Sep-2022, vaccine was administered to a patient at 9:30 AM, which was more than 12 hours. The vaccines received were thawed with a use by date. But they removed from their refrigerator on 08-Sep-2022. Post puncture vial was stored at room temperature on counter under a cup, away from light. The vial did not undergo any temperature excursions. The total amount of time the vial was exposed to room temperature range (8° to 25°C= 46° to 77°F) was 21 hours. No treatment drugs were reported.   Most recent FOLLOW-UP information incorporated above includes: On 09-Sep-2022: Follow-up received included patient date of birth updated.
syncope or seizure still being determined,events  started in june of 08, she has experienced over 100 syncope episodes since that time, a month or so after inoculation, co administered with Hep A, episodes began in june, again in august, september, weekly in november, december, has experienced immobility, nausea, irregular and missed periods, migraine like headaches, left ear pain, leg pain and tingling in hands and feet, lower back pain, to date she has been to the ER 7 times and had two hospital stays for issues of passing out from 3 minutes to over 30 minutes as she passes out repeatedly, no medical treatment other than rest up until this point, she is being admitted for further neurological understanding and a three day hospital evaluation. 2/4/09 Neurology consult received dated 12/22/08 for eval of episodic LOC.  Pt initially began having lapses of consciousness in 6/2008 on vacation.  Seen in ER and found to be dehydrated, possibly r/t alcohol consumption.  Repeat attacks however were with good hydration status. 1 week after 1st episode pt was feeling ill and unable to walk/stand w/o having an episode. W/U (-). Pt may have weeks w/o episodes, but then begin with teeth chattering, then a "head rush", dizziness and the feeling of going to pass out. Holter monitor did not register any abnormalities during episodes.  Episode in 8/2008, pt was unable to roused x 30 minutes. W/U (-). In 12/08 episode did not involve complete LOC but had bifrontal H/A with photophobia after.  Some events involve hand shaking or whole body shaking.   Pt to be admitted for further eval.D/C Summary received for DOS 1/5-8/2009 with D/C DX: Unexplained LOC. PE WNL. One mild event noted during admission with teeth chattering and tremulous movements of the upper extremities, L>R. No LOC. No further events during admission.
Hot flash and feeling light headed 10 minutes after vaccine. Fatigue, weakness, nausea, headache, neck pain left sided developed 1 hours after vaccine. Nausea occurred off and on for 48 hours. Fatigue, dizziness, weakness, headache, loss of appetite, brain fog, joint pain, neck pain, shortness of breath occurred for 3 days. 4 days after vaccine Fatigue, neck pain, headache and weakness still present but developed severe knee pain in bilateral knees.  Not as short of breath but not back to baseline. Diarrhea occurred day of vaccine and continued for 2 more days.
HEADACHE, NECK STIFFNESS, FEVER/CHILLS, NAUSEA, 24 HOURS POST VACCINATION. REFRRED TO NEUROLOGY.
Patient was called back to the clinic and vital signs were taken and were WNL. Patient showed no s/s of any distress and when asked he states no s/s. Provider was notified and also Moderna manufacture and they will update with guidelines. Patient was released.
Itchy on face after about 5 minutes of vaccination. Given one dose of 25mg Diphenhydramine. Felt better after about 1 hour but the patient did want to go to an urgent care as suggested by her PCP.
First weeks he was fuzzy dude to pain on his legs, by the forth week he was crying of pain at night not just during the day. I would help him by week 5 take a bath because his legs where giving up on him i thought he might of hurt him self but saw no bruces on his leg and knees. Three days before he was in hospital he cry so much he was fuzzy he would not eat drink as much he began to puke his food and milk his eye where dark i though he might of got sick but show no flu or sniffles. He would fall and not walk by the time i took him in he leg was big  and knee was big.
9/25/11 9 am awoke with fever, elevated 105 (temporal), checked twice, TYLENOL given, vomited immediately, repeated dose, 1/2 hr later, T decreased 103, slept on & off, on 25th T 10, at pm TYLENOL given at 6:30pm decreased to 99, afebrile on 9/7 & at day care.